Quantitative imaging of coronary blood flow

Area of Science:

• Nuclear Medicine
• Medical Imaging
• Radiochemistry

Background:

• Positron Emission Tomography (PET) is a nuclear medicine imaging modality.
• Introduced in the 1970s, PET has advanced significantly with improved radiotracers and detection systems.
• PET enables diverse clinical applications including cancer detection, Alzheimer's disease staging, and coronary artery disease (CAD) assessment.

Purpose of the Study:

• To describe the processes involved in PET imaging.
• To discuss the application of PET in guiding the treatment of coronary artery disease (CAD).
• To explore the potential and limitations of nanoparticles in PET imaging.

Main Methods:

• Review of the fundamental principles of PET imaging.
• Discussion of clinical applications, with a focus on CAD treatment guidance.
• Exploration of emerging technologies, specifically nanoparticles for PET.

Main Results:

• PET imaging relies on the administration and detection of positron-emitting radiotracers to assess physiological events.
• Advances in PET technology have expanded its utility across various medical fields.
• Nanoparticles show promise as novel agents for PET imaging, though challenges remain.

Conclusions:

• PET is a versatile imaging modality with established roles in oncology, neurology, and cardiology.
• PET plays a crucial role in guiding therapeutic decisions, particularly in CAD management.
• Future directions in PET imaging may involve the use of nanoparticles for enhanced diagnostic capabilities.